Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Ask The Pharmacist: Medication-Assisted Treatment (MAT) for Opioid Use
Medication-assisted treatment (MAT) is a safe and cost-effective option for managing opioid addiction. This method is typically applied along with counseling and other support and involves the use of methadone or buprenorphine and sometimes naltrexone.
Plugged In: EV Collision Insights Q4 2022
In Q4 2022, electric vehicle (EV) repairable claims frequency rose to 1.1% in the U.S. and 2.26% in Canada. Tesla continues to dominate EV market share in both countries with 76.78% in the US and 70.21% in Canada. The Ford Mustang Mach-E moved up to fourth position in U.S. EV frequency, displacing the Tesla Model X. Q4 2022 also saw the first appearance of the Hummer EV in a U.S. collision repair facility (none reported in Canada thus far) as well as the Ford F-150 Lightning EV in a Canadian repair facility following its Q3 2022 debut in U.S. auto body shops.
Plugged-In: EV Collision Insights Q4 2022
In Q4 2022, electric vehicle (EV) repairable claims frequency rose to 1.1% in the U.S. and 2.26% in Canada. Tesla continues to dominate EV market share in both countries with 76.78% in the US and 70.21% in Canada. The Ford Mustang Mach-E moved up to fourth position in U.S. EV frequency, displacing the Tesla Model X. Q4 2022 also saw the first appearance of the Hummer EV in a U.S. collision repair facility (none reported in Canada thus far) as well as the Ford F-150 Lightning EV in a Canadian repair facility following its Q3 2022 debut in U.S. auto body shops.
Integrated PBM Results in Double Digit Savings
How Adjuster Workspace Is Driving Simplified Workflows
With many new adjusters entering the workforce and experienced adjusters retiring or changing careers, organizations are looking for new ways to optimize their current processes.
Mitchell Publishes Electric Vehicle Collision Insights Report
SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the Property and Casualty claims and Collision Repair industries, today announced the availability of its latest trends publication: Plugged-In: EV Collision Insights. The new quarterly report provides auto insurance and collision repair executives with up-to-date information on electric vehicle claims and market data.